Concepedia

Ekkehard Mössner

EM

14

Publications

2.7K

Citations

11

H-Index

1998

Active since

Affiliations

Roche (Switzerland)(Current)

Roche Pharma AG (Germany)

Ludwig-Maximilians-Universität München

Ekkehard Mössner is an author at Roche (Switzerland) specializing in medicine, autoimmunity, and immunology.

Top concepts

Publications per year

1998–2019

14

Publications

14

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity

Ekkehard Mössner, Peter Brünker, Samuel Moser et al. · Blood · 2010 · 929 citations · Full text

Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions

Tilman Schlothauer, Sylvia Herter, Claudia Ferrara et al. · Protein Engineering Design and Selection · 2016 · 388 citations · Full text

, , +24

Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties

Christian Klein, Alfred Lammens, Wolfgang Schäfer et al. · mAbs · 2013 · 366 citations · Full text

, , +18

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

Christina Claus, Claudia Ferrara, Wei Xu et al. · Science Translational Medicine · 2019 · 252 citations · Full text

Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies

Gerhard Niederfellner, Alfred Lammens, Olaf Mundigl et al. · Blood · 2011 · 227 citations · Full text

Rows per page

1–5 of 14